跳至主要内容
临床试验/NCT03546933
NCT03546933终止不适用

A Prospective Multi-centre Observational Study to Validate the Diagnostic Accuracy of a Transportable Magnetocardiograph Device for Acute Coronary Syndrome (ACS), Focusing on Rule-out Capability, in Patients Who Present to the Emergency Department With Chest Pain Symptoms Consistent With ACS

Creavo Medical Technologies Ltd5 个研究点 分布在 1 个国家目标入组 651 人开始时间: 2018年7月17日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
651
试验地点
5
主要终点
Sensitivity and specificity of MCG

研究概览

简要总结

A prospective multi-centre observational study to validate the diagnostic accuracy of a transportable magnetocardiograph device for acute coronary syndrome (ACS), focusing on rule-out capability, in patients who present to the emergency department with chest pain symptoms consistent with ACS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient presents to the ED with chest pain syndrome of suspected cardiac origin (i.e. symptoms consistent with ACS)
  • 18+ year old male or female
  • Patient is willing and able to give written informed consent

排除标准

  • ST-segment Elevation MI (STEMI)
  • Clear non-ischemic cause for symptoms (e.g. trauma)
  • Hemodynamic instability on admission (e.g. BP>220mmHg systolic & >110mmHg diastolic, <80mmHg systolic & <40mmHg diastolic, HR>160bpm)
  • Ventricular tachycardia or fibrillation that cannot be treated effectively
  • Atrial fibrillation
  • Thoracic metal implants
  • Pacemaker or internal defibrillator
  • Pregnancy (if after 20-week period)* or lactation
  • Patient unable to lie down (i.e. supine position) or stay still on the examination bed
  • Patient unable to understand the informed consent process and/or has a poor understanding of English (e.g. English- speaking relative/translator not available)
  • Patient unable to comply with the requirements of the protocol

结局指标

主要结局

Sensitivity and specificity of MCG

时间窗: up to 3 month follow-up

Sensitivity and specificity for diagnosing ACS, focusing on rule-out, in chest pain patients with normal sinus rhythm

次要结局

  • 3.Change in sensitivity and specificity for diagnosing ACS, focusing on rule-out, in chest pain patients with normal sinus rhythm, according to low, intermediate and high PTP groups(up to 3 months follow-up)
  • MACE post-presentation to the ED (rule-out of ACS divided into MCG vs reference standard (adjudicated ACS/non-ACS diagnoses))(through 1 week, 3 month follow-up)
  • Proportion of adverse events and types(up to 3 month follow-up)
  • All-cause mortatility (divided into CV and non-CV causes) proportion(through 1 week, 3 month follow-up)

研究者

发起方
Creavo Medical Technologies Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验